Neural tone and cardio-renal outcomes in patients with type 2 diabetes mellitus: a review of the literature with a focus on SGLT2 inhibitors-Reference-Cited by-同舟云学术

Neural tone and cardio-renal outcomes in patients with type 2 diabetes mellitus: a review of the literature with a focus on SGLT2 inhibitors

Published:2020-11-09 Issue:3 Volume:26 Page:643-652
ISSN:1382-4147
Container-title:Heart Failure Reviews
language:en
Short-container-title:Heart Fail Rev

Author:

Nashawi Mouhamed^ORCID,Sheikh Omar,Battisha Ayman,Ghali Abdullah,Chilton Robert

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10741-020-10046-w.pdf

Reference87 articles.

1. Centers for Disease, C. & Prevention (2017) National chronic kidney disease fact sheet, 2017. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention.

2. Afkarian M et al (2016) Clinical manifestations of kidney disease among US adults with diabetes, 1988–2014. JAMA 316:602–610

3. Einarson TR, Acs A, Ludwig C, Panton UH (2018) Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovascular diabetology 17:83

4. McCullough PA (2019) Cardiorenal risk: an important clinical intersection. Reviews in cardiovascular medicine 3:71–76

5. Bailey CJ, Day C (2019) The future of new drugs for diabetes management. Diabetes Res Clin Pract 155:107785

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of empagliflozin in peripheral diabetic neuropathy of patients with type 2 diabetes mellitus;Medicina Clínica;2024-07

2. Effect of empagliflozin in peripheral diabetic neuropathy of patients with type 2 diabetes mellitus;Medicina Clínica (English Edition);2024-07

3. Cardioprotective Effects of Sodium-Glucose Cotransporter 2 Inhibitors and Their Possible Association With Normalization of the Circadian Index of Heart Rhythm;Texas Heart Institute Journal;2023-12-06

4. Sodium-glucose co-transporter 2 inhibitor add-on therapy for metformin delays diabetic retinopathy progression in diabetes patients: a population-based cohort study;Scientific Reports;2023-10-10

5. NEW DIRECTIONS IN PHARMACOLOGICAL TREATMENT WITH SGLT-2 INHIBITOR MOLECULES IN THE LIGHT OF CURRENT GUIDELINES FOR DIABETES MELLITUS, HEART FAILURE AND KIDNEY DISEASE;FARMACIA;2023-08-31